Citigroup has received an average recommendation of “Moderate Buy” from 20 research firms covering the company. Fourteen analysts currently recommend the stock as a buy, while six maintain a hold rating. The average 12-month price objective across those firms stands at $124.65, reflecting a broad expectation of mid-teens upside over the coming year.

Several major banks have revised their stance on Citigroup in recent months. JPMorgan Chase elevated its recommendation from neutral to overweight and raised its target to $124.00. Oppenheimer boosted its price objective from $141.00 to $144.00 and retained an outperform rating. Wolfe Research and HSBC both reaffirmed outperform/buy ratings with targets of $141.00 and $87.00, respectively. Conversely, DBS Bank trimmed its view from moderate buy to hold in September, indicating some divergence among regionally focused firms.

On January 14th, Citigroup reported fourth-quarter EPS of $1.81, beating the consensus estimate of $1.65 by $0.16. Revenue reached $19.87 billion, up 2.1% year-over-year but below the street’s $20.99 billion forecast. Net margin held at 8.50% and return on equity at 8.28%. Analysts project full-year EPS of $7.53, implying roughly 5% earnings growth in the current fiscal year.

The board declared a quarterly dividend of $0.60, payable February 27th to shareholders of record on February 2nd, representing a 34.4% payout ratio and a 2.0% yield. Hedge funds and institutional investors now own 71.7% of shares outstanding. In the most recent quarter, Hartline Investment added 83,387 shares to its portfolio (0.9% weighting), while Wolff Wiese Magana boosted holdings by 87.6%. Several other wealth managers modestly increased positions, evidencing ongoing confidence from fiduciary clients.